{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:10:46Z","timestamp":1774444246095,"version":"3.50.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine malignancy with a high recurrence rate. Approximately half of the patients are asymptomatic, while others experience symptoms due to the tumor's size or hormone secretion. Ro resection if possible is the best option for treatment of primary as well as locoregional recurrent ACC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>A 20-year-old female who previously underwent open left adrenalectomy for Stage III ACC presented with complaints of heaviness and vague discomfort in the left upper abdomen. Current hormonal assays were normal. Imaging revealed a lesion in the spleen suggestive of recurrence. She underwent elective surgery involving en bloc resection of the spleen, diaphragm, and associated structures. Postoperative recovery was uneventful, histopathology confirmed recurrence and subsequent PET-CT showed no recurrence. She is currently on mitotane and remains symptom-free with no signs of recurrence after initial surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>Complete resection (Ro) if possible, for recurrent and metastatic disease has been linked to long-term survival and offers significant palliative benefits, particularly in cases involving symptomatic steroid production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ACC has a high frequency of local recurrence therefore management of recurrence should be considered from the initial diagnosis. Ro resection of recurrence is the best potential treatment. Follow-up protocols and improving integration between surgical, oncological, and supportive care departments are crucial for overcoming healthcare challenges in Nepal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2024.110095","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T03:27:19Z","timestamp":1722310039000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Loco-regional recurrence of adrenocortical carcinoma: A case report"],"prefix":"10.1097","volume":"122","author":[{"given":"Bikash Chandra","family":"Sah","sequence":"first","affiliation":[{"name":"Department of Surgical Gastroenterology, National Academy of Medical Sciences, Bir Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajjwol","family":"Luitel","sequence":"additional","affiliation":[{"name":"Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, National Academy of Medical Sciences, Bir Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandesh","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, National Academy of Medical Sciences, Bir Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirajan","family":"Subedi","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, National Academy of Medical Sciences, Bir Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Pokhrel","sequence":"additional","affiliation":[{"name":"Department of Surgical Gastroenterology, National Academy of Medical Sciences, Bir Hospital, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"7","key":"R1-59-20260325","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","article-title":"Operative management for recurrent and metastatic adrenocortical carcinoma","volume":"105","author":"Datrice,","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"R2-59-20260325","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211033103","article-title":"Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment","author":"Shariq,","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"5","key":"R3-59-20260325","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew,","year":"2006","journal-title":"World J. Surg."},{"issue":"3","key":"R4-59-20260325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours","volume":"28","author":"Lam,","year":"2017","journal-title":"Endocr. Pathol."},{"issue":"4","key":"R5-59-20260325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5152\/tud.2017.81598","article-title":"Adrenocortical carcinoma: single center experience","volume":"43","author":"\u015ei\u015fman,","year":"2017","journal-title":"Turk. J. Urol."},{"key":"R6-59-20260325","first-page":"635","article-title":"Current management options for recurrent adrenocortical carcinoma","volume":"6","author":"Glover,","year":"2013","journal-title":"Onco. Targets. Ther."},{"issue":"2","key":"R7-59-20260325","first-page":"62","article-title":"Role of Mitotane in adrenocortical carcinoma - review and state of the art","volume":"14","author":"Paragliola,","year":"2018","journal-title":"Eur. Endocrinol."},{"issue":"5","key":"R8-59-20260325","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi,","year":"2023","journal-title":"Int. J. Surg."},{"issue":"11","key":"R9-59-20260325","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/cancers15112873","article-title":"Preclinical models of adrenocortical cancer","volume":"15","author":"Sedlack,","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"R10-59-20260325","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: recommendations of an international consensus conference","volume":"12","author":"Schteingart,","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"R11-59-20260325","article-title":"Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options","volume":"2","author":"Al-Ward,","year":"2022","journal-title":"Endocr. Oncol."},{"issue":"6","key":"R12-59-20260325","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jamcollsurg.2016.08.568","article-title":"Clinical score predicting long-term survival after repeat resection for recurrent adrenocortical carcinoma","volume":"223","author":"Tran,","year":"2016","journal-title":"J. Am. Coll. Surg."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261224008769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261224008769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2024.110095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:23:01Z","timestamp":1774434181000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2024.110095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":12,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2024.110095","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"2024-06-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}